Envveno Medical CORP Schedule 13G passive stakes

Kingdon Capital Management, L.L.C. and affiliated entities have reported beneficial ownership of 5.5% of enVVeno Medical Corporation's common stock as of March 31, 2026.

Northstrive Fund II LP and Braeden Lichti have disclosed beneficial ownership of enVVeno Medical Corp common stock, with Lichti holding a 5.05% stake.

Braeden Lichti and Northstrive Fund II LP have disclosed beneficial ownership of 5.05% of enVVeno Medical Corporation's common stock.

Thomas A. Satterfield, Jr. has disclosed a 9.0% beneficial ownership stake in enVVeno Medical Corporation, totaling 1,822,500 shares.

Nantahala Capital Management and its managing members reported a 3.46% beneficial ownership stake in enVVeno Medical Corporation as of September 30, 2025.

Kingdon Capital Management and related entities have reported a 7.1% beneficial ownership stake in enVVeno Medical Corporation's common stock.